Histamine Receptors as Drug Targets

This book provides an overview of the current state-of-the-art in histamine research, focusing on methodologies for investigating pharmacological properties and therapeutic exploitation of HRs and their ligands. It offers a multi-disciplinary approach to define decision gates for developing effective and safer therapeutic options for prevalent diseases.

\n Format: Paperback / softback
\n Length: 517 pages
\n Publication date: 20 July 2018
\n Publisher: Humana Press Inc.
\n

This comprehensive book delves into the cutting-edge advancements in histamine research, emphasizing the appropriate methodologies to explore the pharmacological properties and therapeutic potential of histamine receptors (HRs) and their ligands. Moreover, the range of techniques presented offers an insightful introduction to complementary cross-methodological disciplines that extend beyond these fields. By adopting a multi-disciplinary approach, this book aims to establish the 'decision gates' that determine the development of more effective and safer therapeutic options for numerous prevalent and debilitating diseases, including asthma, dementia, dermatitis, and arthritis. Written for the Methods in Pharmacology and Toxicology series, the chapters focus on practical, hands-on protocols provided by experts in the respective techniques. Authored by esteemed experts in the field, Histamine Receptors as Drug Targets is an authoritative and thorough resource that seeks to assist pharmacologists, biochemists, drug discovery researchers, molecular biologists, chemists, toxicologists, lab scientists, medical doctors, principle investigators, research scientists, lab directors, and technicians, as well as graduate students worldwide, in advancing their understanding of this vital scientific area.

\n Weight: 994g\n
Dimension: 255 x 177 x 32 (mm)\n
ISBN-13: 9781493983155\n
Edition number: Softcover reprint of the original 1st ed. 2017\n